CalciMedica, Inc. SEC filings CALC
CalciMedica, Inc. has 531 filings in SEC EDGAR's recent list, going back to Nov 8, 2011. Its latest annual report, Form ARS, was filed on Jul 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 31, 2026 | — |
| EFFECT | Filing | Mar 11, 2026 | — |
| CORRESP | Letter to the SEC | Mar 9, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2026 | — |
| EFFECT | Filing | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 7, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2024 | — |
| EFFECT | Filing | Aug 18, 2023 | — |
| CORRESP | Letter to the SEC | Aug 16, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| CERT | 8a cert | Jun 13, 2023 | — |
| 8-A12B | Filing | Jun 13, 2023 | — |
| EFFECT | Filing | Apr 14, 2023 | — |
| CORRESP | Letter to the SEC | Apr 12, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2023 | — |
| D | Filing | Apr 4, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| PRER14A | Filing | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Jan 31, 2023 | — |
| PRER14A | Filing | Jan 31, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| PRER14A | Filing | Jan 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2023 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| 8-A12B | Filing | Sep 21, 2020 | — |
| CORRESP | Letter to the SEC | Sep 8, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 8, 2020 | — |
| CORRESP | Letter to the SEC | Sep 4, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2020 | — |
| DRS | Filing | Jul 31, 2020 | — |
| D | Filing | Aug 15, 2019 | — |
| D/A | Filing | Jun 13, 2018 | — |
| D/A | Filing | Jul 18, 2017 | — |
| D | Filing | May 13, 2016 | — |
| D | Filing | Dec 21, 2015 | — |
| D | Filing | Mar 6, 2015 | — |
| D | Filing | Oct 7, 2014 | — |
| D/A | Filing | Oct 10, 2013 | — |
| D | Filing | Sep 18, 2013 | — |
| D | Filing | Nov 8, 2011 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CALC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534133
- Former names
- CalciMedica, Inc. /DE/ (until Mar 22, 2023); GRAYBUG VISION, INC. (until Mar 15, 2023); GRAYBUG, Inc. (until May 13, 2016); GRAYBUG LLC (until Oct 7, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.